Lista de obras -

Bladder function preservation with brachytherapy, external beam radiation therapy, and limited surgery in bladder cancer patients: Long-term results [corrected].

artículo científico publicado en 2014

Combined microsatellite and FGFR3 mutation analysis enables a highly sensitive detection of urothelial cell carcinoma in voided urine

artículo científico publicado en 2003

Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program

artículo científico publicado en 2002

Controversies in the treatment of high-risk prostate cancer--what is the optimal combination of hormonal therapy and radiotherapy: a review of literature

artículo científico publicado en 2010

CyberKnife stereotactic radiotherapy as monotherapy for low- to intermediate-stage prostate cancer: early experience, feasibility, and tolerance

artículo científico publicado en 2010

Deformation of prostate and seminal vesicles relative to intraprostatic fiducial markers

artículo científico publicado en 2008

Diagnosis of testicular carcinoma in situ‘(intratubular and microinvasive)’ seminoma and embryonal carcinoma using direct enzymatic alkaline phosphatase reactivity on frozen histological sections ⬇️

artículo científico publicado el 16 de febrero de 2011

Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up

artículo científico publicado en 2005

Does "normal" aging imply urinary, bowel, and erectile dysfunction? A general population survey.

artículo científico publicado en 2008

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin.

artículo científico publicado en 2015

FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma

artículo científico publicado en 2004

Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer

artículo científico publicado en 2005

High-Dose-Rate Brachytherapy and External-Beam Radiotherapy for Hormone-Naïve Low- and Intermediate-Risk Prostate Cancer: A 7-Year Experience ⬇️

artículo científico publicado el 26 de enero de 2012

Increasing age is not associated with toxicity leading to discontinuation of treatment in patients with urothelial non-muscle-invasive bladder cancer randomised to receive 3 years of maintenance bacille Calmette-Guérin: results from European Organis

artículo científico publicado en 2016

Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and [...]

artículo científico publicado en 2009

Markers predicting response to bacillus Calmette-Guérin immunotherapy in high-risk bladder cancer patients: a systematic review

artículo científico publicado en 2011

Microsatellite analysis of voided-urine samples for surveillance of low-grade non-muscle-invasive urothelial carcinoma: feasibility and clinical utility in a prospective multicenter study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer tr

artículo científico publicado en 2008

Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non–Muscle-Invasive Bladder Cancer

scientific article published on 09 June 2010

Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications

artículo científico publicado en 2014

Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome

artículo científico publicado en 2003

Patients' perceived burden of cystoscopic and urinary surveillance of bladder cancer: a randomized comparison

artículo científico publicado en 2007

Pelvic exenteration for primary and recurrent gynaecological malignancies

artículo científico publicado en 2006

Prediction of Progression of Non–Muscle-Invasive Bladder Cancer by WHO 1973 and 2004 Grading and by FGFR3 Mutation Status: A Prospective Study

article

Prognosis of primary mucosal penile melanoma: a series of 19 Dutch patients and 47 patients from the literature

artículo científico publicado en 2007

Rotterdam Randomized Pilot Studies of Screening for Prostate Cancer—An Overview After 10 Years

artículo científico publicado en 2005

Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer.

artículo científico publicado en 2013

Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors

scientific article published on 01 November 2003

Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: early results ⬇️

artículo científico publicado el 9 de abril de 2013

Surveillance with microsatellite analysis of urine in bladder cancer patients treated by radiotherapy.

artículo científico publicado en 2003

The development of multiple bladder tumour recurrences in relation to the FGFR3 mutation status of the primary tumour.

artículo científico publicado en 2009

The effect of age on the efficacy of maintenance bacillus Calmette-Guérin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911.

artículo científico publicado en 2014

The management of cerebral metastasis from germ cell cancer; walking the tightrope.

artículo científico publicado en 2008

The pathologist's mean grade is constant and individualizes the prognostic value of bladder cancer grading

artículo científico publicado en 2009

Toxicity and quality of life after high-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer

artículo científico publicado en 2015

Lista de obras de

Bladder function preservation with brachytherapy, external beam radiation therapy, and limited surgery in bladder cancer patients: Long-term results [corrected].

Combined microsatellite and FGFR3 mutation analysis enables a highly sensitive detection of urothelial cell carcinoma in voided urine

Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program

Controversies in the treatment of high-risk prostate cancer--what is the optimal combination of hormonal therapy and radiotherapy: a review of literature

CyberKnife stereotactic radiotherapy as monotherapy for low- to intermediate-stage prostate cancer: early experience, feasibility, and tolerance

Deformation of prostate and seminal vesicles relative to intraprostatic fiducial markers

Diagnosis of testicular carcinoma in situ‘(intratubular and microinvasive)’ seminoma and embryonal carcinoma using direct enzymatic alkaline phosphatase reactivity on frozen histological sections ⬇️

Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up

Does "normal" aging imply urinary, bowel, and erectile dysfunction? A general population survey.

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin.

FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma

Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer

High-Dose-Rate Brachytherapy and External-Beam Radiotherapy for Hormone-Naïve Low- and Intermediate-Risk Prostate Cancer: A 7-Year Experience ⬇️

Increasing age is not associated with toxicity leading to discontinuation of treatment in patients with urothelial non-muscle-invasive bladder cancer randomised to receive 3 years of maintenance bacille Calmette-Guérin: results from European Organis

Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and [...]

Markers predicting response to bacillus Calmette-Guérin immunotherapy in high-risk bladder cancer patients: a systematic review

Microsatellite analysis of voided-urine samples for surveillance of low-grade non-muscle-invasive urothelial carcinoma: feasibility and clinical utility in a prospective multicenter study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer tr

Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non–Muscle-Invasive Bladder Cancer

Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications

Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome

Patients' perceived burden of cystoscopic and urinary surveillance of bladder cancer: a randomized comparison

Pelvic exenteration for primary and recurrent gynaecological malignancies

Prediction of Progression of Non–Muscle-Invasive Bladder Cancer by WHO 1973 and 2004 Grading and by FGFR3 Mutation Status: A Prospective Study

Prognosis of primary mucosal penile melanoma: a series of 19 Dutch patients and 47 patients from the literature

Rotterdam Randomized Pilot Studies of Screening for Prostate Cancer—An Overview After 10 Years

Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer.

Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors

Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: early results ⬇️

Surveillance with microsatellite analysis of urine in bladder cancer patients treated by radiotherapy.

The development of multiple bladder tumour recurrences in relation to the FGFR3 mutation status of the primary tumour.

The effect of age on the efficacy of maintenance bacillus Calmette-Guérin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911.

The management of cerebral metastasis from germ cell cancer; walking the tightrope.

The pathologist's mean grade is constant and individualizes the prognostic value of bladder cancer grading

Toxicity and quality of life after high-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer